Bard Associates Inc. Makes New $3.87 Million Investment in Viemed Healthcare, Inc. $VMD

Bard Associates Inc. acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 339,672 shares of the company's stock, valued at approximately $3,872,000. Bard Associates Inc. owned 0.89% of Viemed Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in VMD. State of Alaska Department of Revenue acquired a new position in shares of Viemed Healthcare during the fourth quarter worth about $25,000. Kemnay Advisory Services Inc. acquired a new stake in Viemed Healthcare in the fourth quarter valued at approximately $46,000. Quarry LP purchased a new position in Viemed Healthcare in the third quarter worth approximately $48,000. AQR Capital Management LLC purchased a new position in Viemed Healthcare in the first quarter worth approximately $90,000. Finally, R Squared Ltd acquired a new position in Viemed Healthcare during the 4th quarter worth approximately $102,000. Institutional investors and hedge funds own 74.24% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Weiss Ratings cut shares of Viemed Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday. Wall Street Zen downgraded Viemed Healthcare from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 15th. Finally, Freedom Capital cut Viemed Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 5th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of "Hold".

Insider Buying and Selling

In other news, insider William Frazier sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total value of $117,200.00. Following the sale, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the sale, the director owned 75,518 shares in the company, valued at approximately $868,457. This trade represents a 20.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 20.60% of the company's stock.

Viemed Healthcare Stock Up 3.3%

VMD stock opened at $8.85 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.02 and a current ratio of 1.13. The company has a fifty day moving average of $10.98 and a 200-day moving average of $9.86. Viemed Healthcare, Inc. has a one year low of $6.05 and a one year high of $12.61. The stock has a market capitalization of $337.10 million, a PE ratio of 24.58 and a beta of 1.10.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.05). The business had revenue of $78.10 million during the quarter, compared to analyst estimates of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. As a group, analysts expect that Viemed Healthcare, Inc. will post 0.42 EPS for the current year.

About Viemed Healthcare

Viemed Healthcare, Inc NASDAQ: VMD is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.

Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source